Evaluation of the Addenbrooke's Cognitive Examination–Revised in a routine cognitive outpatient clinic
Journal of Alzheimer’s Disease · 2026
DOI: 10.1177/13872877261471428 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Journal of Alzheimer’s Disease, 2026. Verfasst von Jan Sebastian Novotný und 14 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Molecular and Translational Medicine, Faculty of Medicine and Dentistry, Palacký University Olomouc, Olomouc, Czech Republic. Hauptthemen laut MEDLINE: Neuropsychological Tests, Cognitive Dysfunction, Dementia. Die Arbeit nennt 48 Literaturangaben. Gefördert von: Ministerstvo Školství, Mládeže a Tělovýchovy.
Abstract (Originalsprache)
Background
The Addenbrooke's Cognitive Examination–Revised (ACE-R) is a widely used multidomain cognitive screening instrument. However, its performance in routine cognitive outpatient clinics with heterogeneous, diagnostically unselected populations remains insufficiently characterized.
Objective
To evaluate the diagnostic accuracy and clinical utility of ACE-R across the spectrum of cognitive impairment in a real-world cognitive outpatient setting.
Methods
This retrospective observational study included 348 consecutive patients attending a cognitive outpatient clinic. Diagnostic accuracy was assessed using binary and multiclass classification, and longitudinal cognitive trajectories were analysed using multilevel modelling.
Results
ACE-R reliably differentiated dementia from non-dementia and distinguished Alzheimer's disease from mild cognitive impairment. Discrimination between subjective cognitive impairment and normal cognition was limited, consistent with the absence of objective cognitive deficits in subjective cognitive impairment. The instrument demonstrated greater sensitivity for cortical dementias than for subcortical conditions. Longitudinal analyses showed significant cognitive decline in Alzheimer's disease.
Conclusions
ACE-R is a practical and clinically useful screening tool for routine outpatient settings, particularly for dementia detection. However, limited sensitivity in early-stage impairment and restricted ability to differentiate dementia subtypes support its use within a multimodal diagnostic framework rather than as a standalone instrument.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Institute of Molecular and Translational Medicine, Faculty of Medicine and Dentistry, Palacký University Olomouc, Olomouc, Czech Republic.
- Department of Psychology and Abnormal Psychology, Faculty of Education, Palacký University Olomouc, Olomouc, Czech Republic.
- The Fritchie Centre, Gloucestershire Health and Care NHS Foundation Trust, Cheltenham, UK.
- Cobalt Medical Charity, Cheltenham, UK.
- Department of Radiology, Gloucestershire Hospitals NHS Foundation Trust, Cheltenham, UK.
- Department of Vascular Neurology, University Medical Centre, Ljubljana, Slovenia.
ORCID-Profile: Senta Frol, Gorazd Bernard Stokin
Förderung
- Ministerstvo Školství, Mládeže a Tělovýchovy
Zitieren
APA
Novotný, J. S., Thatcher, A., Shatti, D., Mofardin, S., Rakuša, M., Kolenc, M., Zupan, M., Frol, S., Popović, K. Š., Oblak, J. P., Bossert, I., Kuruvilla, T., Lyburn, I., Trifiro, G., & Stokin, G. B. (2026). Evaluation of the Addenbrooke's Cognitive Examination–Revised in a routine cognitive outpatient clinic. Journal of Alzheimer’s Disease. https://doi.org/10.1177/13872877261471428
Vancouver
Novotný JS, Thatcher A, Shatti D, Mofardin S, Rakuša M, Kolenc M, et al. Evaluation of the Addenbrooke's Cognitive Examination–Revised in a routine cognitive outpatient clinic. Journal of Alzheimer’s Disease. 2026. doi:10.1177/13872877261471428
BibTeX
@article{Novotn2026,
author = {Novotný, Jan Sebastian and Thatcher, Alexandra and Shatti, David and Mofardin, Sergio and Rakuša, Martin and Kolenc, Matej and Zupan, Matija and Frol, Senta and Popović, Katarina Šurlan and Oblak, Janja Pretnar and Bossert, Irene and Kuruvilla, Tarun and Lyburn, Iain and Trifiro, Giuseppe and Stokin, Gorazd Bernard},
title = {Evaluation of the Addenbrooke's Cognitive Examination–Revised in a routine cognitive outpatient clinic},
journal = {Journal of Alzheimer’s Disease},
year = {2026},
doi = {10.1177/13872877261471428}
}
EUVIMED